More Than a Cleanup Crew: The Expanding Biology of Efferocytosis
Arteriosclerosis, Thrombosis, and Vascular Biology · 2026-02 · 46 (2)
DOI: 10.1161/atvbaha.125.323211 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2026-02. Verfasst von Rajan Pandit und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Physiology (R.P., A.Y.), Louisiana State University Health Sciences Center at Shreveport. Hauptthemen laut MEDLINE: Phagocytosis, Apoptosis, Phagocytes, Cardiovascular Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Efferocytosis, the process by which phagocytes clear apoptotic cells, is essential for tissue homeostasis, inflammation resolution, and repair. Once considered a passive waste-disposal process, efferocytosis is now recognized as a dynamic, immunometabolic program that integrates apoptotic cell clearance with metabolic reprogramming and inflammation resolution. In cardiovascular contexts, efficient efferocytosis limits necrosis, enhances the deposition of wound healing matrix proteins, and promotes tissue healing, whereas impaired clearance drives chronic inflammation and maladaptive tissue remodeling. We review the molecular mechanisms governing efferocytosis, including the interplay of find-me, eat-me, and don’t-eat-me signals with receptor-mediated cytoskeletal remodeling and lysosomal degradation. We highlight how efferocytosis drives lipid efflux, fatty acid oxidation, amino acid catabolism, and nucleotide recycling, processes that sustain continual efferocytosis and resolution programming. Defects in these pathways, amplified by proteolytic cleavage of apoptotic cell receptors, dysregulated metabolism, and inflammatory mediators, underlie impaired efferocytosis in atherosclerosis, myocardial infarction, vascular aging, and metabolic diseases. Finally, we discuss emerging concepts, including nonprofessional phagocyte contributions, crosstalk with adaptive immunity, and therapeutic strategies to enhance efferocytosis or preserve receptor integrity. Collectively, these insights redefine efferocytosis as more than a cleanup mechanism, positioning it as a central contributor to attenuating cardiometabolic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Cellular Physiology (R.P., A.Y.), Louisiana State University Health Sciences Center at Shreveport.
- Department of Integrative Biology and Physiology, Center for Immunology, University of Minnesota, Minneapolis (H.H., J.W.W.).
- Department of Pathology and Translational Pathobiology (A.Y.), Louisiana State University Health Sciences Center at Shreveport.
ORCID-Profile: Hannah Hillman, Jesse W Williams, Arif Yurdagul
Förderung
- NHLBI NIH HHS
- NIAID NIH HHS
Zitieren
APA
Pandit, R., Hillman, H., Williams, J. W., & Yurdagul, A. (2026). More Than a Cleanup Crew: The Expanding Biology of Efferocytosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 46(2). https://doi.org/10.1161/atvbaha.125.323211
Vancouver
Pandit R, Hillman H, Williams JW, Yurdagul A. More Than a Cleanup Crew: The Expanding Biology of Efferocytosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 2026;46(2). doi:10.1161/atvbaha.125.323211
BibTeX
@article{Pandit2026,
author = {Pandit, Rajan and Hillman, Hannah and Williams, Jesse W and Yurdagul, Arif},
title = {More Than a Cleanup Crew: The Expanding Biology of Efferocytosis},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2026},
volume = {46},
number = {2},
doi = {10.1161/atvbaha.125.323211}
}
EUVIMED